Know more

Our use of cookies

Cookies are a set of data stored on a user’s device when the user browses a web site. The data is in a file containing an ID number, the name of the server which deposited it and, in some cases, an expiry date. We use cookies to record information about your visit, language of preference, and other parameters on the site in order to optimise your next visit and make the site even more useful to you.

To improve your experience, we use cookies to store certain browsing information and provide secure navigation, and to collect statistics with a view to improve the site’s features. For a complete list of the cookies we use, download “Ghostery”, a free plug-in for browsers which can detect, and, in some cases, block cookies.

Ghostery is available here for free: https://www.ghostery.com/fr/products/

You can also visit the CNIL web site for instructions on how to configure your browser to manage cookie storage on your device.

In the case of third-party advertising cookies, you can also visit the following site: http://www.youronlinechoices.com/fr/controler-ses-cookies/, offered by digital advertising professionals within the European Digital Advertising Alliance (EDAA). From the site, you can deny or accept the cookies used by advertising professionals who are members.

It is also possible to block certain third-party cookies directly via publishers:

Cookie type

Means of blocking

Analytical and performance cookies

Realytics
Google Analytics
Spoteffects
Optimizely

Targeted advertising cookies

DoubleClick
Mediarithmics

The following types of cookies may be used on our websites:

Mandatory cookies

Functional cookies

Social media and advertising cookies

These cookies are needed to ensure the proper functioning of the site and cannot be disabled. They help ensure a secure connection and the basic availability of our website.

These cookies allow us to analyse site use in order to measure and optimise performance. They allow us to store your sign-in information and display the different components of our website in a more coherent way.

These cookies are used by advertising agencies such as Google and by social media sites such as LinkedIn and Facebook. Among other things, they allow pages to be shared on social media, the posting of comments, and the publication (on our site or elsewhere) of ads that reflect your centres of interest.

Our EZPublish content management system (CMS) uses CAS and PHP session cookies and the New Relic cookie for monitoring purposes (IP, response times).

These cookies are deleted at the end of the browsing session (when you log off or close your browser window)

Our EZPublish content management system (CMS) uses the XiTi cookie to measure traffic. Our service provider is AT Internet. This company stores data (IPs, date and time of access, length of the visit and pages viewed) for six months.

Our EZPublish content management system (CMS) does not use this type of cookie.

For more information about the cookies we use, contact INRA’s Data Protection Officer by email at cil-dpo@inra.fr or by post at:

INRA
24, chemin de Borde Rouge –Auzeville – CS52627
31326 Castanet Tolosan CEDEX - France

Dernière mise à jour : Mai 2018

Menu Logo Principal

LIA BactInflam

Presentation BactInflam

Beneficial bacteria (propionic acid-, lactic acid- or commensal- bacteria), and compounds thereof, could serve as complements or alternatives to current anti-IBD treatments and to antibiotics used in prevention and treatment of mastitis.

International Joint Laboratory  (Laboratoire International Associé / LIA)

Bact-Inflam - INRA-UFMG

Brazilian and French BactInflam partners have been collaborating since 2000.
They co-authored together 90+ scientific papers and book chapters.
They co-supervised 20+ PhD students and 15+ post-docs.
The LIA BactInflam label,  co-signed by INRA and UFMG, strengthens this fruitful collaboration.

collaborations

Bact-Inflam objectives

  • To identify bacterial determinants involved in pro- or anti-inflammatory processes in various context (IBD and mastitis)
  • To characterize inflammatory processes with, as a start point, our models of mammary gland and gut

Bact-Inflam strategy

  • Characterization of the inflammation process and of the bacteria involved in the inflammation (e.g. S. aureus / mastitis)
  • Determination of microbiota composition associated to inflamed or healthy organes
  • Identification of marker species (dysbiosis/inflamed or eubiosis/healthy)
  • Characterization of these biomarkers at the cellular and molecular levels
  • Validation on animal models
  • Development of new therapeutic strategies and or alternatives to allopathic treatments, based on the use of immunomodulatory bacteria or bacterial compounds.
Temas & Objectivos

Apresentação Bactinflam

Bactérias benéficas (bactéria comensais, ácido propiônicas ou ácido lácticas) e seus compostos podem servir como complementos ou alternativas...
Read more
Themes & Objectives

Presentation BactInflam

Beneficial bacteria (propionic acid-, lactic acid- or commensal- bacteria), and compounds thereof, could serve as complements or alternatives to...
Read more
Thèmes & Objectifs

Presentation BactInflam

Beneficial bacteria (propionic acid-, lactic acid- or commensal- bacteria), and compounds thereof, could serve as complements or alternatives to...
Read more